We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Melanoma Development Linked to Relationship Between Pigment Synthesis and Mitochondrial Function

By LabMedica International staff writers
Posted on 11 Jan 2015
Development of melanoma, a potentially fatal type of skin cancer, is linked to the direct relationship between pigment production (melanogenesis) and generation of reactive oxygen species (ROS) by the mitochondria.

Melanogenesis is a highly conserved process in many species that protects cells from UV radiation damage. More...
Although both mitochondrial function and UV radiation damage are well-documented promoters of increased cellular stress, their individual molecular relationships with skin pigmentation have not been clearly resolved.

Investigators at the University of Newcastle (United Kingdom) presented evidence for a direct relationship between cellular melanin content, superoxide flux, and mitochondrial function at Complex II. They examined three types of melanoma skin cancer cell lines that displayed low, medium, or high pigment levels and analyzed their ROS levels and mitochondrial Complex II function.

Results showed that the darker the cells, the higher ROS generation and Complex II function. When cells with lower melanin levels were induced to produce more by augmenting them with L-tyrosine, a building block for melanin production, these cell types gradually exhibited higher pigment levels, while simultaneously showing increased Complex II function.

"This study reports a novel correlation between proteins involved in the bioenergy process within the human skin (i.e., Complex II) and skin pigmentation," said Dr. Mark Birch-Machin, professor of molecular dermatology at Newcastle University. "This leads to interesting possibilities of Complex II playing a central role in coupling stress sensing and cellular adaptation via ROS signaling, and as this study was performed in skin cancer cells, may help in the development of anticancer drugs."

The study was published in the January 2015 issue of the FASEB Journal.

Related Links:

University of Newcastle



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.